drugset / Trial / NCT07166939

45th Multicenter Airway Research Collaboration

NCT07166939

Phase 4 Recruiting 1860 enrolled Massachusetts General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

Timeline

Start
2025-11-07
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled
Subject Salbutamol Unknown Inhaled

Indications